Detailed Information on Publication Record
2023
Escherichia coli from Human Wounds: Analysis of Resistance to β-Lactams and Expression of RND Efflux Pumps
RIHACEK, Martin, Michaela KUTHANOVA, Zbynek SPLICHAL, Vojtech ADAM, Kristyna HRAZDILOVA et. al.Basic information
Original name
Escherichia coli from Human Wounds: Analysis of Resistance to β-Lactams and Expression of RND Efflux Pumps
Authors
RIHACEK, Martin (203 Czech Republic), Michaela KUTHANOVA (203 Czech Republic), Zbynek SPLICHAL (203 Czech Republic), Vojtech ADAM (203 Czech Republic), Kristyna HRAZDILOVA (203 Czech Republic), Radek VESELÝ (203 Czech Republic, belonging to the institution), Ludek ZUREK (203 Czech Republic) and Kristyna CIHALOVA (203 Czech Republic, guarantor)
Edition
INFECTION AND DRUG RESISTANCE, AUCKLAND, DOVE MEDICAL PRESS LTD, 2023, 1178-6973
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30230 Other clinical medicine subjects
Country of publisher
New Zealand
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 3.900 in 2022
RIV identification code
RIV/00216224:14110/23:00133383
Organization unit
Faculty of Medicine
UT WoS
001113170700001
Keywords in English
clinical isolates; ampicillin resistance; resistance mechanisms; antibiotics
Tags
International impact, Reviewed
Změněno: 19/2/2024 15:25, Mgr. Tereza Miškechová
Abstract
V originále
Purpose: Resistance of pathogenic strains of Escherichia coli to beta-lactams, particularly to ampicillin, is on the rise and it is attributed to intrinsic and acquired mechanisms. One important factor contributing to resistance, together with primarily resistance mechanisms, is a mutation and/or an over-expression of the intrinsic efflux pumps in the resistance-nodulation-division (RND) superfamily. Among these efflux pumps, AcrA, AcrB, TolC, and AcrD play an important role in antimicrobial co-resistance, including resistance to beta-lactams.Materials and Methods: Twelve E. coli isolates obtained from patients' wounds and the control strain of E. coli ATCC 25922 were analyzed. The phenotypic resistance of these isolates to selected beta-lactams was assessed by determination of the minimal inhibitory concentration. Additionally, the prevalence of beta-lactamase genes (blaTEM, blaCTX-M, blaSHV, and blaAmpC) was screened by PCR. Realtime qPCR was used to determine the expression of the selected efflux pumps acrA, acrB, tolC, and acrD and the repressor acrR after the exposure of E. coli to ampicillin.Results: Phenotypic resistance to beta-lactams was detected in seven isolates, mainly to ampicillin and piperacillin. This was corroborated by the presence of at least one acquired bla gene in each of these isolates. Although E. coli strains varied in the expression of RND-family efflux pumps after the ampicillin exposure, their gene expression indicated that these pumps did not play a major role in the phenotypic resistance to ampicillin.Conclusion: Each E. coli isolate displayed unique characteristics, differing in minimum inhibitory concentration (MIC) values, prevalence of acquired blaTEM and blaCTX-M genes, and expression of the RND-family pumps. This together demonstrates that these clinical isolates employed distinct intrinsic or acquired resistance pathways for their defense against ampicillin. The prevalence and spread of ampicillin resistant E. coli has to be monitored and the search for ampicillin alternatives is needed.